Loading market dashboard
Intra-Cellular Therapies, Inc.
ITCIHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Intra-Cellular Therapies, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $3.52B | $2.79B - $4.14B | -$2.47B | $15.913 | 4 |
| Dec 2028 | $2.64B | $2.09B - $3.11B | -$1.86B | $11.44 | 3 |
| Dec 2027 | $1.98B | $1.95B - $2.01B | -$1.39B | $7.576 | 9 |
| Dec 2026 | $1.43B | $1.13B - $1.68B | -$1.01B | $4.307 | 10 |
| Dec 2025 | $925.56M | $886.65M - $1.00B | -$650.40M | $0.797 | 6 |
| Dec 2024 | $675.07M | $674.21M - $675.83M | -$474.37M | -$0.629 | 11 |
| Dec 2023 | $513.93M | $407.12M - $604.19M | -$361.14M | -$1.151 | 9 |
| Dec 2022 | $249.37M | $236.16M - $264.36M | -$326.57M | -$2.873 | 6 |
| Dec 2021 | $83.14M | $77.16M - $90.24M | -$72.23M | -$3.454 | 6 |
| Dec 2020 | $22.19M | $20.60M - $24.09M | -$251.11M | -$3.331 | 5 |
| Dec 2018 | $50.0K | $46.4K - $54.3K | -$177.71M | -$2.998 | 5 |
| Dec 2017 | $245.2K | $227.6K - $266.1K | -$213.0K | -$2.087 | 5 |